Skip to main content

Three DOUG Insiders Report Share Buys

October 12, 2022

Cathie Wood's ARK Investment Management is on our list today, as the ETF provider just filed 13Gs for two of its healthcare holdings.

In one of the filings, ARK reported a 10.64% stake in the genomics outfit Ginkgo Bioworks $DNA.

ARK also revealed an increase in its ownership of CareDx $CDNA, from 6.89% at its last filing in February to 10.83% today.

RTW Investments LP disclosed the acquisition of 1,355,932 shares equivalent to $20 million in Rocket Pharmaceuticals $RCKT.

The hedge fund has a massive ownership stake of more than 27%.

Here’s The Hot List, with data through October 11, 2022:

The CEO, CFO, and a director of Douglas Elliman $DOUG filed three separate Form 4s reporting purchases worth a combined $830,440.

This kind of insider activity always stands out.

Mario Gabelli's GAMCO Investors is back on our list today with a 13D filing that reveals an increase of 1% in his ownership stake of Dril-Quip Inc $DRQ.

Over in Washington, Rep. Kevin Hern of Oklahoma reported purchases in two energy stocks, Devon Energy $DVN and Pioneer Natural Resources $PXD.

Last but not least, there was bullish options flow in Boeing $BA, Taiwan Semiconductor $TSM, and AstraZeneca $AZN.

Stay tuned. We'll be back Thursday with more insider action.

If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.

And please reach out with any questions. We love hearing from you!

All Star Charts Team